VALENCIA, Calif., March 17, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today announced ...

Market forces rained on the parade of AVITA Medical, Inc. (NASDAQ:RCEL) shareholders today, when the analysts downgraded their forecasts for this year. Both revenue and earnings per share (EPS) ...

On Tuesday, Avita Medical, Inc. (NASDAQ:RCEL) revised its revenue guidance for the fourth quarter and full year of 2024. The regenerative medicine company adjusted its projections due to ...

The FDA is asking for more information regarding Avita's Recell Go device. The Recell Go is a more automated version of an already approved product for Avita. The company said that it is now hoping to ...

Avita Health System launched a Drug Repository Program allowing donation and redistribution of unexpired medications to qualifying patients. Patients must be Ohio residents, referred by a medical ...

The latest price target for AVITA Medical (NASDAQ:RCEL) was reported by D. Boral Capital on September 15, 2025. The analyst firm set a price target for $14.00 expecting RCEL to rise to within 12 ...

The Food and Drug Administration signs off on a new wound treatment device by Avita Medical. Tech: Avita's Recell. Valencia-based Avita Medical Inc. has received FDA approval for a version of its ...

AVITA Medical has appointed Cary Vance as Interim CEO following the sudden departure of Jim Corbett, along with a Board reshuffle. The company also announced preliminary third-quarter revenue guidance ...

ONTARIO - Avita's plans for building Richland County's third hospital focus on giving consumers new healthcare options while capitalizing on its growing ability to offer more specialized services in ...